Table 5.
The subgroup analysis in smoking status and genotypes of rs46522.
| CAD group n (%) |
Non-CAD group n (%) |
OR (95%CI) | p value | OR′ (95%CI′) | p′ value | |
|---|---|---|---|---|---|---|
| Nonsmoking + T/C or C/C | 102 (26.2) | 103 (37.5) | 1 | 1 | 1 | 1 |
| Nonsmoking + T/T | 87 (22.3) | 79 (28.7) | 0.899 (0.597–1.354) | 0.611 | 0.969 (0.747–1.257) | 0.812 |
| Smoking + T/C or C/C | 94 (24.1) | 57 (20.7) | 1.665 (1.085–2.555) | 0.019 | 1.076 (0.746–1.552) | 0.693 |
| Smoking + T/T | 107 (27.4) | 36 (13.1) | 3.001 (1.883–4.785) | <0.001 | 1.330 (0.884–2.001) | 0.171 |
CAD: coronary artery disease. OR′, 95%CI′, and p′ were after adjustment with age, gender, history of hypertension and diabetes, BMI, fasting glucose, and lipid levels.